SHAREHOLDER ALERT: Monteverde & Associates PC Announces Investigation of Adamas Pharmaceuticals, Inc.

0

NEW YORK, October 15, 2021 / PRNewswire / – Juan Monteverde, founder and managing partner of Monteverde & Associates PC, a nationally-rated brokerage Top 50 in the 2018-2020 ISS Securities Class Action Services report and headquartered at the Empire State Building in New York City, investigation Adamas Pharmaceuticals, Inc. (“ADMS” or the “Company”) (ADMS) relating to its proposed acquisition by Supernus Pharmaceuticals, Inc. Under the terms of the agreement, ADMS shareholders will receive $ 8.10 plus two contingent value rights collective value $ 1.00 in cash per share they own.

The investigation focuses on whether Adamas Pharmaceuticals, Inc. and its board of directors violated securities laws and / or violated their fiduciary duties to the company by 1) failing to conduct a fair process and 2) whether the transaction is correctly evaluated.

Click here for more information: http://monteverdelaw.com/case/adamas-pharmaceuticals-inc. It’s free and there is no cost or obligation for you.

Logo PC Monteverde & Associés

About Monteverde & Associates PC

We are a national securities class action law firm that has collected millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2020 ISS Securities Class Action Services report. Our lawyers have significant experience in M&A litigation and securities class actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of lawyers in a particular area. He was also selected by Martindale-Hubbell as Top Rated Lawyer 2017-2020. Recent successes for our firm include changing the law in a significant victory that lowered the level of liability under Section 14 (e) of the Exchange Act in the Ninth Circuit. Subsequently, our firm managed to preserve this victory by obtaining the rejection of a writ of certiorari granted out of recklessness in the United States Supreme Court. Emulex Corp. vs. Varjabedian, 139 S. Ct. 1407 (2019). Additionally, over the years, the company has recovered or secured more than a dozen mutual funds in cash for shareholders in M&A class actions.

If you own any common stock of the Company and would like additional information and protect your investments for free, please see our website or contact Juan E. Monteverde, Esq. either by email at [email protected] or by phone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
PC MONTEVERDE & ASSOCIATES
The empire state building
350 Fifth Ave. Suite 4405
New York, New York State 10118
united states of america
[email protected]
Phone. : (212) 971-1341

Lawyer advertising. (C) 2021 Monteverde & Associés PC. The law firm responsible for this announcement is Monteverde & Associates PC (www.monteverdelaw.com). Past results do not guarantee a similar result with respect to any future matters.

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-adamas-pharmaceuticals-inc–adms-301401657.html

SOURCE Monteverde & Associés PC


Source link

Leave A Reply

Your email address will not be published.